ReviewNew microbes and new infections2026
Coexistence of endometriosis and human papilloma virus: A systematic review and meta-analysis.
Review in New microbes and new infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Recently, several studies have explored the potential association between endometriosis and human papillomavirus. This study aimed to investigate whether women with endometriosis are prone to human papillomavirus and whether women with human papillomavirus are prone to endometriosis. Method: In this systematic review and meta-analysis, the search was performed on Web of Science, Scopus, and PubMed from inception to August 2025. The quality assessment was performed using the Newcastle-Ottawa Scale. The pooled effect size (OR or proportion) was calculated using random-effects models. Egger's test and Begg's test were used for assessing publication bias. Result: In total 12 studies with 38265 participants were included. The pooled prevalence estimates of human papillomavirus regardless of the type among women with endometriosis was 29.73% [95% confidence interval (CI): 14.218 to 48.149; I Conclusion: Although this study indicates a higher prevalence of human papillomavirus in women with endometriosis, the pooled odds ratios showed that human papillomavirus and endometriosis do not significantly influence the risk of developing each other. The pooled prevalence estimate carries high heterogeneity, which limits interpretation. Additional research is necessary to investigate the relationship between human papillomavirus and endometriosis. Prospero registration code: CRD420251132982.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.